The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...
The launch of Cloudcure's companion app marks the first step in the company's broader roadmap that will introduce additional clinical and technological capabilities. The company is developing features ...
Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...
The Hoffman Process, popular with a growing number of CEOs and celebrities, is often described as ‘10 years of therapy in a ...
Management prioritizes 5%–10% weight loss and acetazolamide titration guided by Frisén grading, OCT, and visual fields; ...
The Citizens Life Sciences Conference 2026 March 11, 2026 9:35 AM EDTCompany ParticipantsAndrew Peters - Senior Vice President ...
Barclays 28th Annual Global Healthcare Conference March 12, 2026 11:30 AM EDTCompany ParticipantsDinesh Patel - ...
Morning Overview on MSN
AI study of protein nanoribbons points to new design rules
Researchers at Pacific Northwest National Laboratory used artificial intelligence to analyze protein nanoribbons, pointing to ...
With World Sleep Day having been observed recently on March 13, NT NETWORK examines why it is important to wake up to the ...
Complementary biochemical and structural findings reveal molecular principles underlying substrate selectivity by a model hyaluronan synthase.
Detailed price information for Americas Gold and Silver Corporation (USA-T) from The Globe and Mail including charting and ...
Through Omada’s GLP-1 Flex Care offering, employers gain a new flexible option to connect employees with anti-obesity medication, virtual care, and lifestyle supportSAN FRANCISCO, March 05, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results